Jesse Channon

When it comes to capital strategy in the cannabis industry, strategic investors are not simply seeking “exposure” to the sector. Instead, their focus is on acquiring specific capabilities—such as compliant supply chains, consistent quality standards, route-to-market leverage, and brands with the potential to expand across markets. In cannabis, the true test of strategy occurs after the deal closes. Integration challenges can arise due to state-by-state fragmentation, quality assurance failure modes, channel conflicts, and concerns about whether the operating system can scale without jeopardizing compliance or the brand itself. Three primary capital strategies are emerging within the industry: * Asset-heavy vertical integration * Pure brand licensing * Hybrid infrastructure platforms Each of these strategies has inherent strengths. Asset-Heavy Vertical Integration Asset-heavy vertical integration is a strategic approach centered on control and synergies across inputs, manufacturing, and distribution. However, this model concentrates regulatory and execution risks, and its effectiveness depends on maintaining a fully utilized footprint and a replicable playbook across different markets. Brand Licensing - (Admitted bias - The Clear Brands has embraced this strategy completely) Licensing offers a strategic advantage for brands looking to expand reach without owning every facility. This approach can deliver option value across various geographies, but it requires rigorous specifications, testing procedures, and partner governance to ensure the brand maintains its consistency everywhere. Hybrid Infrastructure Platforms Hybrid platforms are creating a “shared services” layer, including compliance, QA, manufacturing systems, and distribution standards that brands can connect to. This strategy is particularly appealing for bolt-on opportunities, provided the platform is truly interoperable and not just a standalone solution. The central question is not which model is currently popular, but which approach best reduces operational risk while preserving brand integrity. Ultimately, capital gravitates toward predictability, since repeatable returns depend on it. This principle is consistent across all consumer categories. From a strategic perspective, it’s vital to determine where to place the bet: should you own the assets, own the brand, or own the operating system? The right choice is the one that increases integration velocity while maintaining quality and regulatory durability. #theclearbrands #TWAXbyTheClear #TheClearEFX

11

Scaling Across State Lines: The Ultimate Guide to MSO Success in 2026 ​The cannabis industry is evolving rapidly, and Multi-State Operators (MSOs) are leading the charge by building scalable, repeatable systems that transcend state borders. If you are looking to expand your footprint while maintaining consistency and compliance, our latest deep dive into the Rise of Multi-State Operators provides the strategic blueprint you need to win. ​🚀 Why the MSO Model is Accelerating Now ​Regulatory shifts and demand volatility are rewarding operators who can successfully diversify across different markets, including adult-use, medical, and emerging categories like THCA. By centralizing data and finance while localizing execution, top-tier operators are protecting their margins and building competitive moats through vertical integration. ​🛠️ Key Strategies for Scalable Growth ​To transition from a single-state player to a dominant MSO, your expansion must be auditable and repeatable. Our guide covers the essential pillars of a successful multi-state strategy: ​Centralized Playbooks: Start with a repeatable operating system for licensing, SOPs, and QA to ensure consistency across every facility. ​M&A Precision: Use a structured acquisition funnel to qualify targets based on market access and operational fit, lowering your integration risk. ​Standardized Compliance: Avoid "compliance debt" by unifying your testing cadence, COA storage, and batch tracking under a single, version-controlled library. ​Brand Consistency: Build trust by maintaining a unified brand book and product tiers, even as you adapt messaging for local markets. ​Data-Driven Operations: Allocate inventory and spend based on real-time demand forecasting and margin tracking after logistics costs. ​⚠️ Avoid the Common Pitfalls of Rapid Expansion ​Most MSO failures stem from moving too fast without the proper controls in place. Red flags like unclear SOP ownership or overleveraged expansion timelines can derail even the most ambitious growth plans. Always ensure you have a clear distribution and compliance plan before entering a new territory. ​📋 Is Your Operation MSO-Ready? ​We’ve included a Practical MSO Readiness Checklist to help you audit your current standing. From securing legal counsel and documenting enforced SOPs to defining your 18-month capital plan, this checklist is your roadmap to a safer, faster expansion. ​Standardize your compliance, then scale your distribution.

3

When I open this app I keep seeing people say we need collaboration, not consolidation in the cannabis industry. I think that framing misses the point entirely. When two major companies combine — like Wyld and Grön — their partners don’t get left behind. They get pulled into a bigger ecosystem with more resources and higher expectations. Suddenly the supplier that served one company is now critical infrastructure for both. That is collaboration CREATED by consolidation. But the reality is we DO need consolidation. We have lots of companies that should be products, lots of good assets being under leveraged, lots of talented people working for too many companies. We as an industry need to evolve out of a mindset that every company has a right to exist. Business is darwinism. The strong acquire and grow, the weak get acquired, or die. I’m a huge believer that cannabis and its participants can become a much stronger industry if we all try to find the right dance partners for the next phase. Big, big players (tobacco, alcohol, pharma) are lurking and they will move fast once rescheduling is complete. A fragmented industry with no consolidated value is easy to pick apart. The companies building real partnerships inside larger structures will be the ones still standing. Everyone else will be waiting for someone to save them. Don’t lose sight of where we are in the market maturation cycle. This is the consolidation phase.

139

32 Comments

🎙️ CannaDiva Conversations: Special Episode – BioTrack, Compliance & NY Cannabis The CannaDiva In this special episode, I sit down with Anne Forkutza from BioTrack, New York’s official seed-to-sale tracking provider, for a candid and informative conversation on compliance, accountability, and the realities of track-and-trace in New York State’s cannabis industry. Whether you're a cultivator, processor, distributor, or retailer, this episode is packed with critical insights to help you navigate the transition to BioTrack — with clarity, calm, and community in mind. We discuss: What BioTrack is and how it integrates with NYS OCM Why seed-to-sale traceability matters and who’s responsible The compliance timeline for license holders Common challenges and how to prepare Equity, scale, and supporting small operators in the transition This conversation is a must-listen for anyone in the NY cannabis space looking to stay compliant and informed. Resource Links: Digital Inventory Tag Guide https://lnkd.in/g_vB3jEM https://lnkd.in/guJNmAzt OCM Seed-to-Sale Page https://lnkd.in/g8-uvfVM BioTrack https://lnkd.in/g3CWeVwz https://lnkd.in/gUsFq93a Follow on Instagram @biotrackthc @thecannadiva https://lnkd.in/gr8VDH9q

14

1 Comment